{"id":2412,"date":"2020-04-13T19:31:40","date_gmt":"2020-04-13T19:31:40","guid":{"rendered":"http:\/\/blog.valuengine.com\/?p=2412"},"modified":"2020-04-13T19:34:30","modified_gmt":"2020-04-13T19:34:30","slug":"valuengine-weekly-update-4-10-2020","status":"publish","type":"post","link":"http:\/\/blog.valuengine.com\/index.php\/valuengine-weekly-update-4-10-2020\/","title":{"rendered":"ValuEngine Weekly Update 4\/10\/2020"},"content":{"rendered":"\n<p>Overall percentage of stocks undervalued by ValuEngine quant models drops to 85%. This is still a huge number and rare to see. But it is down from 93% just a week ago. It is still a buyers market long term, but a risky one short term. Today&#8217;s stock pick is ticker DNLI (Denali Therapeutics Inc). Oil\/Energy remains the most undervalued sector. All research on approximately 5,000 stocks, 16 sector groups, and 140 industries has been updated on <a href=\"http:\/\/www.ValuEngine.com\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"www.ValuEngine.com (opens in a new tab)\">www.ValuEngine.com<\/a>.<\/p>\n\n\n\n<p>Free Two Week Trial to all 5,000 plus equities covered by ValuEngine&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.valuengine.com\/pub\/VeSubscribeInfo?pid=1\" target=\"_blank\">HERE<\/a><\/p>\n\n\n\n<p>Financial Advisory Services based on ValuEngine research available through ValuEngine Capital Management, LLC, Click&nbsp;<a href=\"http:\/\/www.valuenginecapital.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">HERE<\/a><\/p>\n\n\n<a href=\"http:\/\/blog.valuengine.com\/wp-content\/uploads\/2020\/04\/200410-VE-WeeklyReport.pdf\" class=\"pdfemb-viewer\" style=\"\" data-width=\"max\" data-height=\"max\" data-mobile-width=\"500\"  data-scrollbar=\"none\" data-download=\"on\" data-tracking=\"on\" data-newwindow=\"on\" data-pagetextbox=\"off\" data-scrolltotop=\"off\" data-startzoom=\"100\" data-startfpzoom=\"100\" data-toolbar=\"bottom\" data-toolbar-fixed=\"off\">200410-VE-WeeklyReport<br\/><\/a>\n<p class=\"wp-block-pdfemb-pdf-embedder-viewer\"><\/p>\n\n\n\n<p>Subscribers log in&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.valuengine.com\/ve\/mainve?pid=1\" target=\"_blank\">HERE<\/a><\/p>\n\n\n\n<p>Free Two Week Trial to all 5,000 plus equities covered by ValuEngine&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.valuengine.com\/pub\/VeSubscribeInfo?pid=1\" target=\"_blank\">HERE<\/a><\/p>\n\n\n\n<p>Financial Advisory Services based on ValuEngine research available through ValuEngine Capital Management, LLC, Click\u00a0<a href=\"http:\/\/www.valuenginecapital.com\/\" target=\"_blank\" rel=\"noreferrer noopener\" aria-label=\"HERE (opens in a new tab)\">HERE<\/a><\/p>\n\n\n\n<p>Paul Henneman | President\/CEO | support@ValuEngine.com | ValuEngine, Inc<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Overall percentage of stocks undervalued by ValuEngine quant models drops to 85%. This is still a huge number and rare to see. But it is down from 93% just a week ago. It is still a buyers market long term, but a risky one short term. Today&#8217;s stock pick is ticker DNLI (Denali Therapeutics Inc). &#8230; <a title=\"ValuEngine Weekly Update 4\/10\/2020\" class=\"read-more\" href=\"http:\/\/blog.valuengine.com\/index.php\/valuengine-weekly-update-4-10-2020\/\" aria-label=\"More on ValuEngine Weekly Update 4\/10\/2020\">Read more<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[130,1,39],"tags":[1517,1631,1632,1630,1479,1518,1505,1633,1471,1510,1467,1462,1066,947,1472,28,1464],"_links":{"self":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2412"}],"collection":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/comments?post=2412"}],"version-history":[{"count":3,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2412\/revisions"}],"predecessor-version":[{"id":2416,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/posts\/2412\/revisions\/2416"}],"wp:attachment":[{"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/media?parent=2412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/categories?post=2412"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/blog.valuengine.com\/index.php\/wp-json\/wp\/v2\/tags?post=2412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}